This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shuxiang Cui: Innovator in Pharmaceutical Technology
Introduction
Shuxiang Cui is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of compounds with therapeutic potential.
Latest Patents
Cui holds a patent for a compound known as 3,4-dihydroisoquinoline and its various derivatives. This invention demonstrates significant inhibitory activity on PRMT5, which is crucial in the context of tumor cell inhibition. The compound shows promise for clinical applications in preventing and treating diseases mediated by PRMT5, highlighting its potential impact on cancer therapies.
Career Highlights
Shuxiang Cui is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work at this company emphasizes his commitment to advancing pharmaceutical innovations. With a focus on developing effective treatments, Cui's research is paving the way for new therapeutic options.
Collaborations
Cui collaborates with esteemed colleagues, including Chuanwu Zhao and Yan Zhang. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Shuxiang Cui's contributions to pharmaceutical technology and his innovative patent reflect his dedication to improving healthcare solutions. His work continues to inspire advancements in the treatment of diseases, particularly in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile